SK Biopharmaceuticals Co., Ltd.

Overview

SK Biopharmaceuticals Co., Ltd. is a leading biopharmaceutical company based in South Korea. The company is focused on the development of innovative treatments for neurological disorders and oncology. As a subsidiary of SK Group, it leverages cutting-edge science and technology to advance breakthrough therapies.

Therapeutic areas

API / Drug Master Files

SK Biopharmaceuticals Co., Ltd. holds 2 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

  • B-NICOTINAMIDE ADENINE DINUCLEOTIDEActive2026-02-18
  • HUMAN UMBILICAL CORD WHARTON'S JELLY MESENCHYMAL STEM CELL EXOSOMESActive2025-03-24

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SK Biopharmaceuticals Co., Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.